Survivin signaling in clinical oncology: a multifaceted dragon.
about
Survivin: A molecular biomarker in cancerDiscovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug deliveryNanoformulated cell-penetrating survivin mutant and its dual actions.Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.MicroRNA regulation and therapeutic targeting of survivin in cancer.Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.The microRNA expression signature of bladder cancer by deep sequencing: the functional significance of the miR-195/497 cluster.Nicorandil protects mesenchymal stem cells against hypoxia and serum deprivation-induced apoptosis.Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.In vivo induction of apoptosis by fucoxanthin, a marine carotenoid, associated with down-regulating STAT3/EGFR signaling in sarcoma 180 (S180) xenografts-bearing mice.Combined inhibition of Wee1 and Hsp90 activates intrinsic apoptosis in cancer cellsIWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expressionTheranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.Nanotechnology based platforms for survivin targeted drug discovery.Monitoring survivin expression in cancer: implications for prognosis and therapy.Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies.Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells.miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway.Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer.Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets.Epigenetic mechanism of survivin dysregulation in human cancer.Recent advances in nanomedicine and survivin targeting in brain cancers.Knockdown of microRNA-29a regulates the expression of apoptosis-related genes in MCF-7 breast carcinoma cells.Effects of HSYA on the proliferation and apoptosis of MSCs exposed to hypoxic and serum deprivation conditions.MicroRNA-195: a review of its role in cancers
P2860
Q26823439-B7954A22-9AC0-4CA9-8120-C765C1AFD628Q28652407-848A214E-C353-4314-9FBB-A601E4DE5252Q33904982-A9383EE8-44A6-4F00-82C2-D45CA6A568A6Q34062021-226DD44B-4729-4694-8A6F-FD79CE59B1B7Q34991312-DAFA8416-9E3A-497B-8DE0-0CE1B705E00BQ35073199-19485F20-1531-4CDB-97AB-E3CEDA430F71Q35092566-36CD9F3C-ECAC-4193-989F-96EFCFC5A440Q35849951-F6F21C01-4E75-4FE5-B5FB-C93C65782530Q35914683-EBDE5EDA-EE20-425D-BE3F-A6609219B74AQ36329883-9EE2E909-9060-4B20-9F64-9A457915AF43Q36338764-5E7811DD-BF35-42DE-BCB9-72AF11779A68Q36413716-0D2EDFBC-A19C-40C8-AB9B-427570DAEC89Q36776653-7C0A4012-1F0D-41E4-AE3A-AB076459D93BQ37437269-FFD8D27C-6F10-4C50-87F4-CEE8DA727429Q38040859-E11DF17F-AAE4-49EE-9DB4-22DF516097BBQ38126394-A5B7AF63-4202-438A-BF39-221CA0A4A4A5Q38188591-B420C6D2-D20F-4065-9DDC-50522C9A6010Q38300295-D0E4AAE8-9912-48F0-BC8E-F08F3C5A97D5Q38602174-B8378117-8A1A-43DF-A013-996EEA1A99B3Q38811077-2364D32A-38A1-4847-9D6E-F3D6274BFC82Q38883702-28626465-63C4-4ED2-8DA0-32EDF6227745Q38924340-3F72899B-DC10-42CD-8490-593DD38A4CA5Q38985281-15AA50C4-CE90-45F6-8D70-06D140746E49Q39432577-6CD240A9-0F14-43AC-9FC4-8858C1868AEAQ47215045-7E203DEF-C120-423F-BDBA-E7C7676290E7Q47378913-C9D998C7-8532-4B54-9596-3C54B6EFF883Q49590876-FAA2574C-428A-4F92-B1F4-76B7DC6C6321Q55406358-F0AA940F-92F6-4AE4-8BAB-81F2533D635AQ58547821-C1E43434-DA67-4160-8080-D83AFAD5F97E
P2860
Survivin signaling in clinical oncology: a multifaceted dragon.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Survivin signaling in clinical oncology: a multifaceted dragon.
@en
type
label
Survivin signaling in clinical oncology: a multifaceted dragon.
@en
prefLabel
Survivin signaling in clinical oncology: a multifaceted dragon.
@en
P2860
P356
P1476
Survivin signaling in clinical oncology: a multifaceted dragon.
@en
P2093
Rupinder K Kanwar
Sishir K Kamalapuram
P2860
P304
P356
10.1002/MED.21264
P577
2012-06-11T00:00:00Z